Research Article

Evaluation of clinical pharmacist interventions on drug-related problems in the gastroenterology ward

Volume: 26 Number: 3 June 28, 2025

Evaluation of clinical pharmacist interventions on drug-related problems in the gastroenterology ward

Abstract

Integrating clinical pharmacists in a multidisciplinary patient care team improves the treatment process by identifying and resolving drug-related problems (DRPs). The aim of the study was to determine the effect of clinical pharmacist intervention for DRPs in the gastroenterology service. The first period of the study was conducted between 15.06.2018 and 15.02.2019. Eighty patients admitted to the gastroenterology ward, who used at least one medication, were included in ‘the study group’. The clinical pharmacist participated in ward rounds and made interventions to solve identified DRPs. In the second period of the study, the control group consisted of 80 patients admitted to the same ward between 01.03.2019 and 06.06.2019. DRPs were determined only from the data obtained from the hospital system in the control group. DRPs were classified according to the European Pharmaceutical Care Network (PCNE V9.1). A total of 136 and 46 with an average of 1.7 and 0.57 DRPs per patient (p≤0.01) were identified in the study and control groups, respectively. Of the DRPs in the study group, 59 were related to treatment effectiveness, while 61 were related to treatment safety. Likewise, 21 DRPs were related to treatment effectiveness in the control group, while 12 were related to treatment (p≤0.01). 65% of the interventions were made at the physician level and 49% at the drug level. 97% (n=133) of the total interventions were accepted. The number of DRPs was significantly reduced in the control group within the time frame after the clinical pharmacist intervention period. In conclusion, clinical pharmacists' importance in detecting and preventing DRPs in the gastroenterology ward has been demonstrated.

Keywords

References

  1. [1] Viktil KK, Blix HS. The impact of clinical pharmacists on drug-related problems and clinical outcomes. Basic Clin Pharmacol Toxicol. 2008;102(3):275-280. [CrossRef]
  2. [2] https://www.pcne.org/ Pharmaceutical Care Network Europe (PCNE). https://www.pcne.org/ (Accessed date: 03.01.2021).
  3. [3] Naples JG, Hanlon JT, Schmader KE, Semla TP. Recent Literature on Medication Errors and Adverse Drug Events in Older Adults. J Am Geriatr Soc. 2016;64(2):401-408. [CrossRef]
  4. [4] Salvi F, Marchetti A, D'Angelo F, Boemi M, Lattanzio F, Cherubini A. Adverse Drug Events as a Cause of Hospitalization in Older Adults. Drug Saf 35, 29–45 (2012). [CrossRef]
  5. [5] Gleason KM, McDaniel MR, Feinglass J, et al. Results of the Medications at Transitions and Clinical Handoffs (MATCH) study: an analysis of medication reconciliation errors and risk factors at hospital admission. J Gen Intern Med. 2010;25(5):441-447. [CrossRef]
  6. [6] Unroe KT, Pfeiffenberger T, Riegelhaupt S, Jastrzembski J, Lokhnygina Y, Colón-Emeric C. Inpatient medication reconciliation at admission and discharge: A retrospective cohort study of age and other risk factors for medication discrepancies. Am J Geriatr Pharmacotherapy. 2010;8(2):115-126. [CrossRef]
  7. [7] Reis WC, Scopel CT, Correr CJ, Andrzejevski VM. Analysis of clinical pharmacist interventions in a tertiary teaching hospital in Brazil. Einstein (Sao Paulo). 2013;11(2):190-196. [CrossRef]
  8. [8] Pippins JR, Gandhi TK, Hamann C, et al. Classifying and predicting errors of inpatient medication reconciliation. J Gen Intern Med. 2008;23(9):1414-1422. [CrossRef]

Details

Primary Language

English

Subjects

Pharmaceutical Toxicology

Journal Section

Research Article

Publication Date

June 28, 2025

Submission Date

April 11, 2022

Acceptance Date

April 14, 2022

Published in Issue

Year 2022 Volume: 26 Number: 3

APA
Ceylan, C., Sancar, M., Beceren, A., Demir, A., Kuş, C., & Omurtag, G. Z. (2025). Evaluation of clinical pharmacist interventions on drug-related problems in the gastroenterology ward. Journal of Research in Pharmacy, 26(3), 687-696. https://izlik.org/JA59MT64ZP
AMA
1.Ceylan C, Sancar M, Beceren A, Demir A, Kuş C, Omurtag GZ. Evaluation of clinical pharmacist interventions on drug-related problems in the gastroenterology ward. J. Res. Pharm. 2025;26(3):687-696. https://izlik.org/JA59MT64ZP
Chicago
Ceylan, Cengizhan, Mesut Sancar, Ayfer Beceren, Ali Demir, Coşkun Kuş, and Gülden Zehra Omurtag. 2025. “Evaluation of Clinical Pharmacist Interventions on Drug-Related Problems in the Gastroenterology Ward”. Journal of Research in Pharmacy 26 (3): 687-96. https://izlik.org/JA59MT64ZP.
EndNote
Ceylan C, Sancar M, Beceren A, Demir A, Kuş C, Omurtag GZ (June 1, 2025) Evaluation of clinical pharmacist interventions on drug-related problems in the gastroenterology ward. Journal of Research in Pharmacy 26 3 687–696.
IEEE
[1]C. Ceylan, M. Sancar, A. Beceren, A. Demir, C. Kuş, and G. Z. Omurtag, “Evaluation of clinical pharmacist interventions on drug-related problems in the gastroenterology ward”, J. Res. Pharm., vol. 26, no. 3, pp. 687–696, June 2025, [Online]. Available: https://izlik.org/JA59MT64ZP
ISNAD
Ceylan, Cengizhan - Sancar, Mesut - Beceren, Ayfer - Demir, Ali - Kuş, Coşkun - Omurtag, Gülden Zehra. “Evaluation of Clinical Pharmacist Interventions on Drug-Related Problems in the Gastroenterology Ward”. Journal of Research in Pharmacy 26/3 (June 1, 2025): 687-696. https://izlik.org/JA59MT64ZP.
JAMA
1.Ceylan C, Sancar M, Beceren A, Demir A, Kuş C, Omurtag GZ. Evaluation of clinical pharmacist interventions on drug-related problems in the gastroenterology ward. J. Res. Pharm. 2025;26:687–696.
MLA
Ceylan, Cengizhan, et al. “Evaluation of Clinical Pharmacist Interventions on Drug-Related Problems in the Gastroenterology Ward”. Journal of Research in Pharmacy, vol. 26, no. 3, June 2025, pp. 687-96, https://izlik.org/JA59MT64ZP.
Vancouver
1.Cengizhan Ceylan, Mesut Sancar, Ayfer Beceren, Ali Demir, Coşkun Kuş, Gülden Zehra Omurtag. Evaluation of clinical pharmacist interventions on drug-related problems in the gastroenterology ward. J. Res. Pharm. [Internet]. 2025 Jun. 1;26(3):687-96. Available from: https://izlik.org/JA59MT64ZP